These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 9202037

  • 1. Evidence for a direct interaction between insulin receptor substrate-1 and Shc.
    Kasus-Jacobi A, Perdereau D, Tartare-Deckert S, Van Obberghen E, Girard J, Burnol AF.
    J Biol Chem; 1997 Jul 04; 272(27):17166-70. PubMed ID: 9202037
    [Abstract] [Full Text] [Related]

  • 2. Evidence for the direct interaction of the insulin-like growth factor I receptor with IRS-1, Shc, and Grb10.
    Dey BR, Frick K, Lopaczynski W, Nissley SP, Furlanetto RW.
    Mol Endocrinol; 1996 Jun 04; 10(6):631-41. PubMed ID: 8776723
    [Abstract] [Full Text] [Related]

  • 3. Insulin receptor substrate-1 enhances growth hormone-induced proliferation.
    Liang L, Zhou T, Jiang J, Pierce JH, Gustafson TA, Frank SJ.
    Endocrinology; 1999 May 04; 140(5):1972-83. PubMed ID: 10218944
    [Abstract] [Full Text] [Related]

  • 4. Functional importance of amino-terminal domain of Shc for interaction with insulin and epidermal growth factor receptors in phosphorylation-independent manner.
    Sasaoka T, Ishihara H, Sawa T, Ishiki M, Morioka H, Imamura T, Usui I, Takata Y, Kobayashi M.
    J Biol Chem; 1996 Aug 16; 271(33):20082-7. PubMed ID: 8702728
    [Abstract] [Full Text] [Related]

  • 5. Insulin receptor substrate 2 and Shc play different roles in insulin-like growth factor I signaling.
    Kim B, Cheng HL, Margolis B, Feldman EL.
    J Biol Chem; 1998 Dec 18; 273(51):34543-50. PubMed ID: 9852124
    [Abstract] [Full Text] [Related]

  • 6. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides.
    van der Geer P, Wiley S, Lai VK, Olivier JP, Gish GD, Stephens R, Kaplan D, Shoelson S, Pawson T.
    Curr Biol; 1995 Apr 01; 5(4):404-12. PubMed ID: 7542991
    [Abstract] [Full Text] [Related]

  • 7. Phosphotyrosine binding domains of Shc and insulin receptor substrate 1 recognize the NPXpY motif in a thermodynamically distinct manner.
    Farooq A, Plotnikova O, Zeng L, Zhou MM.
    J Biol Chem; 1999 Mar 05; 274(10):6114-21. PubMed ID: 10037694
    [Abstract] [Full Text] [Related]

  • 8. Shc binding to nerve growth factor receptor is mediated by the phosphotyrosine interaction domain.
    Dikic I, Batzer AG, Blaikie P, Obermeier A, Ullrich A, Schlessinger J, Margolis B.
    J Biol Chem; 1995 Jun 23; 270(25):15125-9. PubMed ID: 7541035
    [Abstract] [Full Text] [Related]

  • 9. Interaction between the phosphotyrosine binding domain of Shc and the insulin receptor is required for Shc phosphorylation by insulin in vivo.
    Isakoff SJ, Yu YP, Su YC, Blaikie P, Yajnik V, Rose E, Weidner KM, Sachs M, Margolis B, Skolnik EY.
    J Biol Chem; 1996 Feb 23; 271(8):3959-62. PubMed ID: 8626723
    [Abstract] [Full Text] [Related]

  • 10. Evidence for a differential interaction of SHC and the insulin receptor substrate-1 (IRS-1) with the insulin-like growth factor-I (IGF-I) receptor in the yeast two-hybrid system.
    Tartare-Deckert S, Sawka-Verhelle D, Murdaca J, Van Obberghen E.
    J Biol Chem; 1995 Oct 06; 270(40):23456-60. PubMed ID: 7559507
    [Abstract] [Full Text] [Related]

  • 11. Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain.
    Gustafson TA, He W, Craparo A, Schaub CD, O'Neill TJ.
    Mol Cell Biol; 1995 May 06; 15(5):2500-8. PubMed ID: 7537849
    [Abstract] [Full Text] [Related]

  • 12. Functional importance of Shc tyrosine 317 on insulin signaling in Rat1 fibroblasts expressing insulin receptors.
    Ishihara H, Sasaoka T, Ishiki M, Takata Y, Imamura T, Usui I, Langlois WJ, Sawa T, Kobayashi M.
    J Biol Chem; 1997 Apr 04; 272(14):9581-6. PubMed ID: 9083103
    [Abstract] [Full Text] [Related]

  • 13. Growth hormone stimulates the tyrosine kinase activity of JAK2 and induces tyrosine phosphorylation of insulin receptor substrates and Shc in rat tissues.
    Thirone AC, Carvalho CR, Saad MJ.
    Endocrinology; 1999 Jan 04; 140(1):55-62. PubMed ID: 9886807
    [Abstract] [Full Text] [Related]

  • 14. Cellular effects of phosphotyrosine-binding domain inhibitors on insulin receptor signaling and trafficking.
    Giorgetti-Peraldi S, Ottinger E, Wolf G, Ye B, Burke TR, Shoelson SE.
    Mol Cell Biol; 1997 Mar 04; 17(3):1180-8. PubMed ID: 9032245
    [Abstract] [Full Text] [Related]

  • 15. Src-family tyrosine kinases in activation of ERK-1 and p85/p110-phosphatidylinositol 3-kinase by G/CCKB receptors.
    Daulhac L, Kowalski-Chauvel A, Pradayrol L, Vaysse N, Seva C.
    J Biol Chem; 1999 Jul 16; 274(29):20657-63. PubMed ID: 10400698
    [Abstract] [Full Text] [Related]

  • 16. Tyrosine phosphorylation-dependent and -independent role of Shc in the regulation of IGF-1-induced mitogenesis and glycogen synthesis.
    Sasaoka T, Ishiki M, Wada T, Hori H, Hirai H, Haruta T, Ishihara H, Kobayashi M.
    Endocrinology; 2001 Dec 16; 142(12):5226-35. PubMed ID: 11713219
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the insulin and insulin-like growth factor 1 mitogenic intracellular signaling pathways.
    Sasaoka T, Ishiki M, Sawa T, Ishihara H, Takata Y, Imamura T, Usui I, Olefsky JM, Kobayashi M.
    Endocrinology; 1996 Oct 16; 137(10):4427-34. PubMed ID: 8828504
    [Abstract] [Full Text] [Related]

  • 18. Insulin signals to prenyltransferases via the Shc branch of intracellular signaling.
    Goalstone ML, Leitner JW, Berhanu P, Sharma PM, Olefsky JM, Draznin B.
    J Biol Chem; 2001 Apr 20; 276(16):12805-12. PubMed ID: 11278505
    [Abstract] [Full Text] [Related]

  • 19. Roles of insulin receptor substrate-1 and Shc on insulin-like growth factor I receptor signaling in early passages of cultured human fibroblasts.
    Takahashi Y, Tobe K, Kadowaki H, Katsumata D, Fukushima Y, Yazaki Y, Akanuma Y, Kadowaki T.
    Endocrinology; 1997 Feb 20; 138(2):741-50. PubMed ID: 9003010
    [Abstract] [Full Text] [Related]

  • 20. Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells.
    Sakaguchi K, Okabayashi Y, Kido Y, Kimura S, Matsumura Y, Inushima K, Kasuga M.
    Mol Endocrinol; 1998 Apr 20; 12(4):536-43. PubMed ID: 9544989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.